Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric catalytic synthesis for chiral fluorinated building blocks. Enhances drug development efficiency and supply chain reliability for pharmaceutical intermediates.
Patent CN1968958A details a novel asymmetric copper complex method for high-purity cyclopropane intermediates, offering significant cost reduction in agrochemical manufacturing.
Novel asymmetric synthesis of (3R)-3-tertbutyldimethylsiloxy-6-dialkoxyphosphono-5-oxo-tertbutyl hexanate via chiral resolution-free route for high-purity statin production.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Patent CN1144796C details a high-yield route for 2R-propyl octanoic acid intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN114751849A reveals a novel asymmetric Baeyer-Villiger oxidation route for brivaracetam intermediates, offering superior chiral purity and significant cost reduction in API manufacturing.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Patent CN108456143A details a high-yield asymmetric route for Pregabalin intermediates ensuring supply chain stability and significant cost reduction for global pharmaceutical manufacturing.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Novel patent CN106810485A enables high-purity chiral biphenylpyrrolidone production. Eliminating protecting groups reduces waste and enhances supply chain reliability for global pharmaceutical partners.
Patent CN109942553A details a novel one-step asymmetric catalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel biocatalytic method for S-2-(4-nitrophenyl)oxirane production. Delivers high purity, cost-effective, and scalable processes for global pharmaceutical intermediate supply chains.
Efficient 6-step route to (+)-γ-lycorane from lactone. High purity, scalable process for pharma intermediates reducing cost and lead time.
Patent CN101891678A details efficient Heck coupling for 4-(N,N-dimethyl)aminopyridine derivatives, offering cost reduction in chiral catalyst manufacturing and scalable pharma intermediate production.
Novel Z-isomer pathway for Ezetimibe synthesis offering higher yields. Cost-effective manufacturing solution for pharmaceutical intermediates.
Advanced asymmetric synthesis of tetrahydroxanthone dimers via patent CN107216306A. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110776488B details an efficient 8-step asymmetric synthesis of (-)-Brazilin. Discover cost-effective manufacturing strategies for this bioactive natural product.
Patent CN1233608C details a novel route for (2S,3S,7S)-3,7-dimethyl-2-pentadecanol esters using (S)-malic acid, offering cost reduction in agrochemical manufacturing.
Novel method for avibactam intermediate using L-camphorsulfonamide. High yield, stereoselective route for reliable pharmaceutical intermediate supplier.
Patent CN105439929B details a cost-effective ezetimibe intermediate synthesis with high yield and scalable industrial processes for global supply chains.